TACR1 and prostate carcinoma: These results, taken together, suggest that elevated NK1R expression can turn on the NEtD process in adenocarcinoma prostate cancer cells, promoting their transition into the neuroendocrine lineage and accelerating their cell survival, growth, and therapy resistance.